Where Compassion Meets Cardiovascular Excellence

CT Coronary Angiogram and Calcium Score — What They Tell You About Your Heart

Home Blogs

CT Coronary Angiogram and Calcium Score — What They Tell You About Your Heart

Dr Bhishma Chowdary cardiologist in Hyderabad

Two of the most powerful non-invasive cardiac investigations available today are the CT coronary angiogram (CCTA) and the coronary artery calcium (CAC) score. Both use a CT scanner, both assess your coronary arteries, and both are performed without placing any catheter inside the body — yet they answer very different clinical questions and are used in very different situations. Understanding the difference helps patients and their families make sense of what their doctor is recommending and why.

Part 1: The coronary artery calcium (CAC) score

What is a calcium score?

A coronary artery calcium scan is a specialised CT scan that detects and quantifies calcium deposits in the walls of the coronary arteries. It requires no injection, no contrast dye, and typically takes less than 10 minutes. The result is a single number — the Agatston score — that reflects the total amount of calcified plaque in your coronary arteries.

Calcium in the coronary artery wall is a marker of atherosclerosis — the same process that eventually causes heart attacks. It does not form overnight; it accumulates over years as cholesterol plaques harden and calcify. A calcium score is therefore a direct measure of your accumulated atherosclerotic burden — how much disease has been silently building in your arteries, regardless of whether you have symptoms yet.

Why calcium score matters

The calcium score is one of the strongest predictors of future heart attack risk available — in many studies outperforming traditional risk factors like cholesterol, blood pressure, and smoking history when it comes to predicting who will actually have a cardiac event in the next 10 years.

How is the calcium score calculated?

The Agatston score is calculated by multiplying the area of each calcified plaque by a density factor. The scores from all coronary arteries are summed to produce the total CAC score. It is reproducible, standardised, and can be compared across time — making it useful for tracking progression.

What do the numbers mean?

CAC = 0 (Zero score) No detectable calcium in the coronary arteries. The 'power of zero' — a CAC score of 0 in someone over 40 is associated with a very low 10-year cardiovascular event rate (less than 1–2%). Can confidently defer or avoid statin therapy in borderline-risk patients. However, does not completely exclude soft non-calcified plaque, particularly in very young patients.
CAC 1–99 (Mild) Some calcium present. Mildly elevated risk. Lifestyle optimisation is strongly recommended. Statin therapy warranted in most patients at this level, particularly if other risk factors are present.
CAC 100–399 (Moderate) Moderate atherosclerotic burden. Statin therapy clearly indicated. Aggressive risk factor management — LDL target below 70 mg/dL, blood pressure control, diabetes management. Stress testing or CCTA may be considered if symptoms are present.
CAC 400–999 (Severe) High atherosclerotic burden — equivalent to established cardiovascular disease risk. High-intensity statin therapy mandatory. LDL target below 55 mg/dL. Further investigation with stress testing or CCTA appropriate.
CAC ≥ 1000 (Very high / extensive) Extensive calcification — a distinct very-high-risk phenotype identified in recent 2024–2025 studies. Very high risk of cardiac events. Treat as equivalent to established coronary artery disease. Urgent cardiology review and aggressive medical therapy. Coronary angiogram or CCTA often indicated to assess for obstructive disease.

Who should have a calcium score?

Current ACC/AHA and ESC guidelines recommend CAC scoring as a risk-refinement tool — not a screening test for everyone, but a decision aid in specific clinical situations:

  • Adults aged 40 to 75 with borderline or intermediate 10-year cardiovascular risk (typically calculated as 5–20%) where the decision to start statin therapy is uncertain
  • Patients who are reluctant to start statins — a calcium score of 0 is a powerful motivator for lifestyle change and reassurance that statins can be safely deferred
  • Patients who are questioning whether to continue statins — a high score reinforces the need for treatment
  • Patients with a strong family history of premature heart disease to assess their personal trajectory
  • Asymptomatic South Asian individuals over 40 — given the higher prevalence of premature CAD and elevated Lp(a) in this population, calcium scoring has particular value as an early risk stratification tool
  • Patients with diabetes being assessed for cardiovascular risk stratification

Special relevance for South Asians

Studies show that South Asians develop coronary artery calcium at younger ages and with higher scores for a given level of traditional risk factors compared to Western populations. A calcium score test at age 40–45 in an asymptomatic Indian patient with a family history can genuinely change clinical management — revealing significant atherosclerosis years before symptoms would otherwise prompt investigation.

What the calcium score cannot tell you

The CAC score has important limitations that are worth understanding:

  • A score of 0 does not guarantee safety — young patients can have soft, non-calcified plaques that are not detected by calcium scoring but can still rupture and cause a heart attack. A calcium score of 0 in someone under 40 with multiple risk factors still warrants clinical assessment.
  • The CAC score does not show the degree of narrowing in the arteries — only the amount of calcium. A high score confirms significant atherosclerosis but does not tell you whether any specific artery is obstructed.
  • CAC scoring does not guide revascularisation decisions — that requires either a conventional angiogram or CT coronary angiogram.
  • CAC is not appropriate for patients who already have established coronary artery disease, prior heart attacks, or stents — the question of how much disease exists has already been answered.

Part 2: CT coronary angiogram (CCTA)

What is a CT coronary angiogram?

A CT coronary angiogram (CCTA) is a non-invasive imaging study that produces detailed, three-dimensional pictures of the coronary arteries — showing both calcified and non-calcified plaque, and critically, whether any artery is significantly narrowed (obstructed). It requires an intravenous injection of iodine-based contrast dye and a heart rate below approximately 65 beats per minute for optimal image quality.

Unlike a calcium score which only detects calcified plaque, CCTA visualises the entire plaque burden — including soft, lipid-rich non-calcified plaques that are often the most vulnerable to rupture and the most likely to cause a sudden heart attack. CCTA therefore gives a much more complete picture of coronary artery disease than calcium scoring alone.

What can CCTA show that calcium scoring cannot?

Degree of stenosis Whether a coronary artery is narrowed by less than 50% (non-obstructive), 50–70% (intermediate), or more than 70% (obstructive). Obstructive disease may require angioplasty or surgery.
Non-calcified plaque Soft lipid-rich plaques that are not detected by calcium scoring — including high-risk plaque features such as low-attenuation plaque and the napkin-ring sign, which are associated with increased risk of plaque rupture.
Plaque composition Whether plaques are predominantly calcified (more stable) or mixed/non-calcified (potentially more vulnerable). The SCOT-HEART trial (10-year outcomes published 2025) showed that low-attenuation plaque burden on CCTA was the strongest predictor of future heart attack, outperforming calcium score and stenosis severity alone.
Coronary artery anomalies Unusual origins or courses of coronary arteries — a cause of sudden cardiac death in young athletes.
Pre-TAVR assessment CCTA of the aortic root and access vessels is mandatory before every TAVR procedure — measuring the aortic annulus dimensions for valve sizing and assessing the iliofemoral vessels for catheter access.
Pre-CTO planning CT angiography before complex CTO-PCI maps the occlusion length, cap morphology, calcium burden, and distal vessel — critical for procedure planning.

The SCOT-HEART trial — why CCTA is changing guidelines

The SCOT-HEART trial — a landmark Scottish randomised controlled trial — followed over 4,000 patients with stable chest pain for 10 years. The 10-year results published in The Lancet in January 2025 demonstrated that patients whose management was guided by CCTA had a 41% reduction in fatal or non-fatal heart attack compared to standard care. CCTA-guided management led to more appropriate use of preventive medications and earlier revascularisation in patients with significant disease — preventing events rather than just responding to them.

These results have reinforced international guideline recommendations to use CCTA as the preferred first-line investigation for patients with stable chest pain and intermediate pre-test probability of coronary artery disease — ahead of exercise stress testing in many situations.

Who needs a CT coronary angiogram?

  • Stable chest pain or breathlessness with intermediate pre-test probability of coronary artery disease — the most common indication
  • Atypical chest pain where the diagnosis is uncertain — CCTA can rule out significant coronary artery disease with very high negative predictive value
  • Abnormal ECG or echocardiogram in an asymptomatic patient where coronary disease is suspected
  • Pre-operative cardiac assessment before major non-cardiac surgery in patients with cardiac risk factors
  • Evaluation of known or suspected coronary anomalies
  • Mandatory pre-TAVR planning — aortic annulus sizing, access vessel assessment
  • Pre-CTO PCI planning — detailed lesion characterisation
  • Evaluation of coronary bypass graft patency — CCTA is excellent for assessing whether surgical grafts remain open
  • Unexplained heart failure — to determine whether coronary artery disease is the underlying cause

How is CCTA performed?

The procedure is straightforward and performed as an outpatient investigation:

  • Beta-blocker medication is given (orally or intravenously) to slow the heart rate below 65 bpm — essential for sharp, motion-free images. Patients on regular beta-blockers may not need additional medication.
  • Sublingual nitrate (GTN spray) is given just before scanning to dilate the coronary arteries and improve image quality.
  • Contrast dye is injected intravenously through a cannula placed in the arm. You will feel a warm flush briefly as the dye circulates — this is normal and passes within seconds.
  • The CT scan itself takes approximately 5 to 10 seconds — the entire preparation and scan process takes about 30 to 45 minutes.
  • The images are then reconstructed and analysed by a cardiologist experienced in cardiac CT interpretation.

CCTA versus conventional (invasive) coronary angiogram — how to choose

CCTA preferred when: Stable symptoms, intermediate pre-test probability, ruling out disease, bypass graft assessment, pre-operative evaluation, anomaly assessment, pre-TAVR planning. No catheter needed — safe outpatient procedure.
Conventional angiogram preferred when: High pre-test probability of obstructive disease, acute coronary syndrome (heart attack or unstable angina), known significant disease requiring assessment for revascularisation, symptoms strongly suggesting obstructive disease, abnormal stress test with high-risk features.
Key advantage of CCTA Non-invasive. No arterial access. Can be performed as outpatient. Excellent for ruling out disease (high negative predictive value). Shows plaque composition, not just stenosis degree.
Key advantage of invasive angiogram Allows simultaneous angioplasty if significant blockage found (ad-hoc PCI). Gold standard for severity assessment. Allows FFR/IVUS/OCT measurement. Required when revascularisation is being planned.

An important practical point

A CCTA that reveals significant (>70%) stenosis in a coronary artery will typically be followed by a conventional invasive coronary angiogram — to confirm the finding and proceed to angioplasty or stenting if appropriate. CCTA is therefore a triage tool in this setting, not a final answer. However, for the many patients where CCTA shows no significant disease or only mild non-obstructive plaque, it avoids an invasive procedure entirely.

Part 3: CAC score vs CCTA — which test is right for you?

Use CAC score when: You have no symptoms but want to understand your cardiovascular risk. You are uncertain whether to start statins. Your doctor needs to refine your 10-year cardiovascular risk estimate. You have a strong family history and want an objective assessment of your coronary artery burden. Best for asymptomatic risk stratification.
Use CCTA when: You have chest pain or breathlessness and your doctor needs to know whether significant coronary artery disease is present. You need a detailed anatomical map of your coronary arteries. Pre-operative assessment is required. Pre-procedural planning for TAVR or complex PCI is needed. Best for symptomatic investigation and anatomical assessment.
Both together? In some clinical situations — particularly when a high calcium score raises suspicion of obstructive disease — the cardiologist may recommend CCTA after calcium scoring to determine whether any blockage is significant. Both tests can be performed in the same session on some CT scanners.

Radiation exposure — is it safe?

Both tests use ionising radiation from the CT scanner, which is a reasonable concern for patients. Current generation CT scanners with dose reduction technology have brought radiation doses down considerably:

CAC score Very low dose — approximately 1 to 2 millisieverts (mSv). Equivalent to a few months of natural background radiation. For context, a standard chest X-ray delivers approximately 0.1 mSv.
CCTA Moderate dose — approximately 2 to 5 mSv with modern dose-reduction protocols. Higher doses (up to 10–15 mSv) with older or non-optimised protocols. Equivalent to roughly 1 to 2 years of background radiation.
Conventional angiogram Variable — typically 3 to 10 mSv for a diagnostic-only procedure, higher for complex interventions.

For most adult patients over 40 being investigated for cardiovascular disease, the radiation dose from either test is clinically acceptable given the diagnostic benefit. For younger patients and women of childbearing age, the risk-benefit is discussed specifically before recommending CT-based cardiac imaging.

What happens after an abnormal result?

After a high calcium score (CAC > 100)

  • High-intensity statin therapy started or intensified — LDL target below 55–70 mg/dL depending on overall risk
  • Aspirin consideration in selected patients — discussed case by case
  • Aggressive risk factor control — blood pressure, diabetes, smoking, weight
  • CCTA or stress testing to assess for obstructive disease if symptoms are present
  • Follow-up calcium score in 3 to 5 years to track progression in asymptomatic patients

After a CCTA showing significant stenosis (>70%)

  • Cardiology review with Dr. Bhishma Chowdary to discuss findings
  • Invasive coronary angiogram planned — to confirm the degree of narrowing and assess suitability for angioplasty
  • FFR/RFR physiological assessment during angiogram to confirm functional significance of borderline lesions
  • Coronary angioplasty and stenting if indicated — can be performed as an ad-hoc procedure at the time of diagnostic angiogram
  • Bypass surgery referral for complex multivessel or left main disease, following Heart Team discussion

After a CCTA showing no significant disease (CAC 0, no stenosis)

Reassuring result — but not a licence to ignore risk factors

A CCTA showing no obstructive coronary disease and a calcium score of 0 in a symptomatic patient is genuinely reassuring — it effectively rules out coronary artery disease as the cause of symptoms. However, it does not mean cardiovascular risk factors should be ignored. Lifestyle modification, blood pressure control, and diabetes management remain important to prevent future disease developing.

Availability at AIG Hospitals, Hyderabad

Cardiac CT angiography and coronary artery calcium scoring are available at AIG Hospitals, Gachibowli, Hyderabad. The cardiac CT programme is supported by:

  • State-of-the-art multi-detector CT scanner with cardiac imaging capability and ECG gating
  • Cardiac CT interpretation by Dr. Bhishma Chowdary — who uses CCTA routinely for pre-TAVR planning, pre-CTO assessment, and symptomatic coronary evaluation
  • Integrated reporting — CCTA findings are reviewed alongside clinical history and echocardiography to provide a complete cardiac assessment
  • Seamless pathway from CCTA to invasive angiogram and angioplasty when required — all in the same centre

Frequently asked questions

Do I need to fast before a calcium score or CCTA?

For a calcium score: no fasting is required. For a CCTA: fasting for 4 hours before the procedure is recommended, as beta-blockers and contrast dye are used. Avoid caffeine for 12 hours before CCTA as it raises heart rate and can affect image quality.

Can CCTA replace a conventional angiogram?

For ruling out disease in low-to-intermediate risk patients, yes — CCTA has excellent sensitivity and negative predictive value for excluding obstructive coronary artery disease. However, if significant disease is found, a conventional angiogram will still be needed to enable intervention (angioplasty/stenting). CCTA and conventional angiogram are complementary tests, not direct replacements for each other.

My calcium score is very high — does that mean I need a stent?

Not necessarily. A high calcium score confirms significant atherosclerotic burden but does not tell you whether any specific artery is obstructed enough to cause reduced blood flow. Many patients with high calcium scores have diffuse but non-obstructive disease — managed medically with statins, blood pressure control, and lifestyle changes, without needing stenting. A CCTA or functional stress test is needed to determine whether any specific blockage is haemodynamically significant.

My CCTA was normal — can I stop my blood pressure or cholesterol medications?

No. A normal CCTA means no significant coronary artery blockage is currently present — but it does not mean your cardiovascular risk factors have resolved. Blood pressure medications, statins, and diabetes medications should be continued as prescribed. Stopping preventive medications after a reassuring CCTA is a common mistake that significantly increases the risk of future disease developing.

Is CCTA safe during pregnancy?

CCTA involves ionising radiation and contrast dye and is generally avoided during pregnancy unless absolutely necessary. Alternative investigations such as echocardiography and V/Q nuclear scanning are preferred for pregnant patients with cardiac concerns. If you are pregnant or may be pregnant, always inform your cardiologist before any CT-based imaging.

Consult Dr. Bhishma Chowdary at AIG Hospitals, Hyderabad

Call/WhatsApp: +91-9000352998

Email: bhishmachowdary@gmail.com

Location: AIG Hospitals, Gachibowli, Hyderabad — 500032

Clinic hours: Monday to Saturday, 10:00 AM to 4:00 PM